Terms: = Breast cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2
425 results:
1. Ononin triggers ferroptosis-mediated disruption in the triple negative breast cancer both in vitro and in vivo.
Gong G; Wan Y; Liu Y; Zhang Z; Zheng Y
Int Immunopharmacol; 2024 May; 132():111959. PubMed ID: 38554442
[TBL] [Abstract] [Full Text] [Related]
2. Involvement of ferroptosis in eribulin-induced cytotoxicity in ovarian clear cell carcinoma.
Azumi M; Kusama K; Yoshie M; Nakano S; Tsuru A; Kato T; Tamura K
Eur J Pharmacol; 2024 May; 971():176544. PubMed ID: 38552939
[TBL] [Abstract] [Full Text] [Related]
3. SBFI26 induces triple-negative breast cancer cells ferroptosis via lipid peroxidation.
He G; Zhang Y; Feng Y; Chen T; Liu M; Zeng Y; Yin X; Qu S; Huang L; Ke Y; Liang L; Yan J; Liu W
J Cell Mol Med; 2024 Apr; 28(7):e18212. PubMed ID: 38516826
[TBL] [Abstract] [Full Text] [Related]
4. An ATPase-Mimicking MXene nanozyme pharmacologically breaks the ironclad defense system for ferroptosis cancer therapy.
Wang H; Liu X; Yan X; Du Y; Pu F; Ren J; Qu X
Biomaterials; 2024 Jun; 307():122523. PubMed ID: 38432004
[TBL] [Abstract] [Full Text] [Related]
5. Peiminine triggers ferroptosis to inhibit breast cancer growth through triggering nrf2 signaling.
Yi N; Wang L; Jiang Z; Xu G; Li L; Zhang Y; Tan Y
Tissue Cell; 2024 Apr; 87():102323. PubMed ID: 38412577
[TBL] [Abstract] [Full Text] [Related]
6. A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic Her2-negative breast cancer.
Shatsky RA; Batra-Sharma H; Helsten T; Schwab RB; Pittman EI; Pu M; Weihe E; Ghia EM; Rassenti LZ; Molinolo A; Cabrera B; Breitmeyer JB; Widhopf GF; Messer K; Jamieson C; Kipps TJ; Parker BA
Breast Cancer Res; 2024 Feb; 26(1):32. PubMed ID: 38408999
[TBL] [Abstract] [Full Text] [Related]
7. Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo.
Dibra D; Xiong S; Moyer SM; El-Naggar AK; Qi Y; Su X; Kong EK; Korkut A; Lozano G
Sci Adv; 2024 Feb; 10(7):eadk1835. PubMed ID: 38354236
[TBL] [Abstract] [Full Text] [Related]
8. Paris saponin VII promotes ferroptosis to inhibit breast cancer via nrf2/GPX4 axis.
Yan C; Xuan F
Biochem Biophys Res Commun; 2024 Feb; 697():149524. PubMed ID: 38252991
[TBL] [Abstract] [Full Text] [Related]
9. breast cancer cells have an increased ferroptosis risk induced by system x
Xue W; Yu Y; Yao Y; Zhou L; Huang Y; Wang Y; Chen Z; Wang L; Li X; Wang X; Du R; Shen Y; Xu Q
Redox Biol; 2024 Apr; 70():103034. PubMed ID: 38211443
[TBL] [Abstract] [Full Text] [Related]
10. Interplay of oxidative stress, cellular communication and signaling pathways in cancer.
Iqbal MJ; Kabeer A; Abbas Z; Siddiqui HA; Calina D; Sharifi-Rad J; Cho WC
Cell Commun Signal; 2024 Jan; 22(1):7. PubMed ID: 38167159
[TBL] [Abstract] [Full Text] [Related]
11. Danggui Buxue Tang improves therapeutic efficacy of doxorubicin in triple negative breast cancer via ferroptosis.
Gong G; Ganesan K; Liu Y; Huang Y; Luo Y; Wang X; Zhang Z; Zheng Y
J Ethnopharmacol; 2024 Apr; 323():117655. PubMed ID: 38158099
[TBL] [Abstract] [Full Text] [Related]
12. Screening fructosamine-3-kinase (FN3K) inhibitors, a deglycating enzyme of oncogenic nrf2: Human FN3K homology modelling, docking and molecular dynamics simulations.
Beeraka NM; Zhang J; Mandal S; Vikram P R H; Liu J; B M N; Zhao D; Vishwanath P; B M G; Fan R
PLoS One; 2023; 18(11):e0283705. PubMed ID: 37910519
[TBL] [Abstract] [Full Text] [Related]
13. Wogonin Diminishes Radioresistance of breast cancer via Inhibition of the nrf2/HIF-1[Formula: see text] Pathway.
Wang T; Wang P; Wang S; Ma Y; Zhao Z; Long F
Am J Chin Med; 2023; 51(8):2243-2262. PubMed ID: 37903716
[TBL] [Abstract] [Full Text] [Related]
14. FOXA2 Suppression by TRIM36 Exerts Anti-Tumor Role in Colorectal cancer Via Inducing nrf2/GPX4-Regulated Ferroptosis.
Liu X; Yan C; Chang C; Meng F; Shen W; Wang S; Zhang Y
Adv Sci (Weinh); 2023 Dec; 10(35):e2304521. PubMed ID: 37875418
[TBL] [Abstract] [Full Text] [Related]
15. Combinatorial Implications of nrf2 Inhibitors with FN3K Inhibitor:
Beeraka NM; Zhang J; Zhao D; Liu J; A U C; Vikram Pr H; Shivaprakash P; Bannimath N; Manogaran P; Sinelnikov MY; Bannimath G; Fan R
Curr Pharm Des; 2023; 29(30):2408-2425. PubMed ID: 37861038
[TBL] [Abstract] [Full Text] [Related]
16. Ochratoxin A promotes chronic enteritis and early colorectal cancer progression by targeting Rinck signaling.
Liu X; Yan C; Chang C; Meng F; Shen W; Wang S; Zhang Y
Phytomedicine; 2024 Jan; 122():155095. PubMed ID: 37844381
[TBL] [Abstract] [Full Text] [Related]
17. The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer.
Xia L; Ma W; Afrashteh A; Sajadi MA; Fakheri H; Valilo M
Biochem Med (Zagreb); 2023 Oct; 33(3):030504. PubMed ID: 37841775
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic Worth of nrf2/BACH1/HO-1 Protein Expression in the Development of breast cancer.
Barnes P; Agbo E; Wang J; Amoani B; Kwaku Opoku Y; Okyere P; Saahene RO
Med Princ Pract; 2023; 32(6):369-378. PubMed ID: 37827129
[TBL] [Abstract] [Full Text] [Related]
19. The Therapeutic Effects of MUC1-C shRNA@Fe
Li Z; Guo T; Zhao S; Lin M
Int J Nanomedicine; 2023; 18():5651-5670. PubMed ID: 37822991
[TBL] [Abstract] [Full Text] [Related]
20. Neutrophils resist ferroptosis and promote breast cancer metastasis through aconitate decarboxylase 1.
Zhao Y; Liu Z; Liu G; Zhang Y; Liu S; Gan D; Chang W; Peng X; Sung ES; Gilbert K; Zhu Y; Wang X; Zeng Z; Baldwin H; Ren G; Weaver J; Huron A; Mayberry T; Wang Q; Wang Y; Diaz-Rubio ME; Su X; Stack MS; Zhang S; Lu X; Sheldon RD; Li J; Zhang C; Wan J; Lu X
Cell Metab; 2023 Oct; 35(10):1688-1703.e10. PubMed ID: 37793345
[TBL] [Abstract] [Full Text] [Related]
[Next]
